<DOC>
	<DOCNO>NCT02066545</DOCNO>
	<brief_summary>The primary objective study evaluate safety efficacy once-daily topical application CLS001 1 % , 1.75 % 2.5 % topical gel compare vehicle topical gel subject inflammatory acne vulgaris</brief_summary>
	<brief_title>Safety Efficacy Study CLS001Topical Gel Compared Vehicle Subjects With Inflammatory Acne Vulgaris</brief_title>
	<detailed_description />
	<mesh_term>Acne Vulgaris</mesh_term>
	<criteria>Male nonpregnant female subject facial acne vulgaris , 12 year age old . Subjects â‰¥20 inflammatory facial lesion ( papule , pustule ) inclusive nose , maximum 9 inflammatory pustule . An Investigator 's Global Assessment ( IGA ) Moderate ( 3 ) Severe ( 4 ) Subjects acne conglobate , acne fulminans , secondary acne ( chloracne , druginduced acne , polycystic ovarian syndrome , etc . ) Subjects great 75 facial noninflammatory lesion ( open and/or close comedo ; exclude nose ) Subjects 2 facial nodulocystic lesion</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>